Uma candidatura feita para esta oferta — um currículo e uma carta de apresentação personalizados que vão ao encontro do anúncio.
Convatec is hiring for a Financial Planning & Analysis role focused on budgeting, forecasting, and business performance analysis. The role collaborates with Finance Business Partners, BU leaders, and global teams to deliver insightful planning and reporting across units.
The position requires strong FP&A experience, financial modelling, and BI tooling such as Power BI, within a hybrid working setup. English fluency is essential.
Financial Planning & Analysis work focuses on short and long-term financial planning and/or financial analysis of business operations for the purpose of measuring and forecasting future business performance.
This includes:
Hybrid working – 1 day per week in the office, driven by business requirements, as Convatec has a flexible approach to office working.
Finance Business Partners BU Commercial Directors Commercial Leadership team Sales Force Excellence Global Marketing Global Operations Technology & Innovation BI Reporting Master Data Management
Our ambitions will bring the very best out in you. You’ll be pushed to aim higher and really own your work. You’ll be encouraged and supported to make things happen, too. It can be challenging. But, as the progress you make will help improve the lives of millions, it’ll be worth it. This is stepping up to a challenge. This is work that’ll move you. #LI-AP1 #LI-Hybrid
About Convatec Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention, treatment for hard to heal wounds, at-risk skin and ulcerated tissue to supporting debilitating conditions, improved patient outcomes and reduced care costs. Convatec's revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit: http://www.convatecgroup.com. Convatec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence & critical care, and infusion care. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. If you would like to know how we intend to use your data following your application please refer to our full data privacy policy on the following link: https://www.convatecgroup.com/privacy-policy/